Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Invested Capital (2021 - 2026)

HeartSciences' Invested Capital history spans 6 years, with the latest figure at $2.7 million for Q1 2026.

  • For Q1 2026, Invested Capital rose 48.44% year-over-year to $2.7 million; the TTM value through Jan 2026 reached $2.7 million, up 48.44%, while the annual FY2025 figure was $205171.0, 97.2% down from the prior year.
  • Invested Capital reached $2.7 million in Q1 2026 per HSCS's latest filing, down from $4.2 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $8.6 million in Q1 2024 to a low of -$6.1 million in Q2 2022.
  • Average Invested Capital over 5 years is $1.7 million, with a median of $1.8 million recorded in 2025.
  • Peak YoY movement for Invested Capital: crashed 252.37% in 2023, then surged 3447.59% in 2024.
  • A 5-year view of Invested Capital shows it stood at $1.1 million in 2022, then plummeted by 252.37% to -$1.6 million in 2023, then surged by 343.48% to $4.0 million in 2024, then increased by 4.13% to $4.2 million in 2025, then crashed by 36.59% to $2.7 million in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Invested Capital are $2.7 million (Q1 2026), $4.2 million (Q4 2025), and $3.1 million (Q3 2025).